Skip to main content

Arcadia Biosciences, Inc.

RKDA
Exchange
Nasdaq
Industry
Crude Petroleum & Natural Gas
SEC CIK
0001469443

No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.

Holders of 5% or more of RKDA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Arcadia Biosciences, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of RKDA
HolderLatest formStakeChangeFirst filedLatest filingFiling
Armistice Capital, LLC13G7.75%159.4K sharesNewMay 15, 20261 filingMay 15, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Arcadia Biosciences, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on RKDA
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 202611:28 AM ETArmistice Capital, LLCand 1 other13G7.75%159.4K sharesNewMar 31, 2026SEC
Jan 3, 202512:41 PM ETSabby Management, LLCand 2 others13G/A4.90%68.1K shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Arcadia Biosciences, Inc. shares.

No Form 144 notices for Arcadia Biosciences, Inc. are on file.